Literature DB >> 28993004

Cerebral amyloid angiopathy-related cognitive impairment: The search for a specific neuropsychological pattern.

M Planton1, N Raposo1, J-F Albucher1, J Pariente2.   

Abstract

Cerebral amyloid angiopathy is diagnosed in stroke units after lobar intracerebral hemorrhage. CAA can also be diagnosed in memory clinics when patients are referred for cognitive impairment assessment, and may be a reason for admission to emergency or neurology departments because of rapidly progressive cognitive or neurological decline, or a transient focal neurological episode. CAA may even be observed in older community-dwelling individuals. Neuropsychological impairment in CAA has been described over the past 20 years. The symptoms most commonly reported are perceptual speed, episodic memory, semantic memory, attention and executive function, and global cognitive impairments. Psychiatric symptoms, such as personality changes, behavioral disturbances and depression, have been more recently described. CAA is also a risk factor for the development of dementia, and its relationship with Alzheimer's disease has been demonstrated in post-mortem studies. Yet, despite the increase in literature on CAA-related cognitive and psychiatric symptoms, the specific characteristics of symptoms in CAA are difficult to assess because of the substantial prevalence of comorbidities such as small vessel disease due to high blood pressure, Lewy body disease and, of course, AD, all of which act as important confounding factors. Also, within the entity of CAA itself, the additive and perhaps synergistic effects of each lesion on cognition remain to be assessed. In the present paper, the focus is on the latest evidence of neuropsychological impairment observed in CAA patients, and the emergence of a possible specific neuropsychological profile due to CAA is also discussed.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Cerebral amyloid angiopathy; Neuropsychological impairment; Transient focal neurological episode

Mesh:

Year:  2017        PMID: 28993004     DOI: 10.1016/j.neurol.2017.09.006

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  6 in total

1.  TDP-43 Pathology Exacerbates Cognitive Decline in Primary Age-Related Tauopathy.

Authors:  Denis S Smirnov; David P Salmon; Douglas Galasko; Steven D Edland; Donald P Pizzo; Vanessa Goodwill; Annie Hiniker
Journal:  Ann Neurol       Date:  2022-07-11       Impact factor: 11.274

2.  Detection of varicella zoster virus antigen and DNA in two cases of cerebral amyloid angiopathy.

Authors:  Teresa Mescher; Philip J Boyer; Andrew N Bubak; James E Hassell; Maria A Nagel
Journal:  J Neurol Sci       Date:  2021-01-09       Impact factor: 3.181

3.  A Novel Model of Mixed Vascular Dementia Incorporating Hypertension in a Rat Model of Alzheimer's Disease.

Authors:  Paul Denver; Heather D'Adamo; Shuxin Hu; Xiaohong Zuo; Cansheng Zhu; Chihiro Okuma; Peter Kim; Daniel Castro; Mychica R Jones; Carmen Leal; Marisa Mekkittikul; Elham Ghadishah; Bruce Teter; Harry V Vinters; Gregory Michael Cole; Sally A Frautschy
Journal:  Front Physiol       Date:  2019-10-24       Impact factor: 4.566

4.  Distinct brain regional proteome changes in the rTg-DI rat model of cerebral amyloid angiopathy.

Authors:  Joseph M Schrader; Feng Xu; William E Van Nostrand
Journal:  J Neurochem       Date:  2021-08-17       Impact factor: 5.546

5.  Age-at-Onset and APOE-Related Heterogeneity in Pathologically Confirmed Sporadic Alzheimer Disease.

Authors:  Denis S Smirnov; Douglas Galasko; Annie Hiniker; Steven D Edland; David P Salmon
Journal:  Neurology       Date:  2021-03-15       Impact factor: 11.800

6.  Longitudinal Cognitive Decline in a Novel Rodent Model of Cerebral Amyloid Angiopathy Type-1.

Authors:  Dominique L Popescu; William E Van Nostrand; John K Robinson
Journal:  Int J Mol Sci       Date:  2020-03-28       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.